Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow conversion efficiency. Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.25 Billion ≈ $183.09 Million USD) by net assets (CN¥8.50 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)

Cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Starlake Bioscience Co Inc Zhaoqing Guan share price for real-time trading data and today's change.

Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Conversion Ratio Explained

Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong ranked by their cash flow conversion efficiency. Also see Starlake Bioscience Co Inc Zhaoqing Guan stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
NationGate Holdings Berhad KLSE:0270	0.091x
Burke & Herbert Financial Services Corp. Common Stock NASDAQ:BHRB	0.046x
SPG Co. Ltd KQ:058610	0.025x
Beijing Cuiwei Tower Co Ltd SHG:603123	-0.003x
Altareit PA:AREIT	0.051x
Capitol Federal Financial Inc NASDAQ:CFFN	0.017x
Helix Energy Solutions Group Inc NYSE:HLX	0.015x
TotalEnergies EP Gabon S.A. PA:EC	0.068x

Annual Cash Flow Conversion Efficiency for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)

The table below shows the annual cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. Review Starlake Bioscience Co Inc Zhaoqing Guan free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.45 Billion ≈ $1.24 Billion	CN¥1.29 Billion ≈ $189.06 Million	0.153x	-48.80%
2024-12-31	CN¥8.03 Billion ≈ $1.18 Billion	CN¥2.40 Billion ≈ $350.87 Million	0.299x	+12.86%
2023-12-31	CN¥7.66 Billion ≈ $1.12 Billion	CN¥2.03 Billion ≈ $296.48 Million	0.265x	+10.25%
2022-12-31	CN¥6.93 Billion ≈ $1.01 Billion	CN¥1.66 Billion ≈ $243.28 Million	0.240x	+121.16%
2021-12-31	CN¥1.78 Billion ≈ $259.83 Million	CN¥192.63 Million ≈ $28.19 Million	0.108x	-27.57%
2020-12-31	CN¥1.67 Billion ≈ $244.23 Million	CN¥249.99 Million ≈ $36.58 Million	0.150x	+6.82%
2019-12-31	CN¥1.52 Billion ≈ $222.47 Million	CN¥213.17 Million ≈ $31.19 Million	0.140x	+164.58%
2018-12-31	CN¥956.42 Million ≈ $139.95 Million	CN¥50.69 Million ≈ $7.42 Million	0.053x	+20.96%
2017-12-31	CN¥914.14 Million ≈ $133.77 Million	CN¥40.05 Million ≈ $5.86 Million	0.044x	+14.12%
2016-12-31	CN¥1.07 Billion ≈ $156.93 Million	CN¥41.17 Million ≈ $6.02 Million	0.038x	+1365.65%
2015-12-31	CN¥1.05 Billion ≈ $153.37 Million	CN¥2.75 Million ≈ $401.72K	0.003x	+119.01%
2014-12-31	CN¥1.47 Billion ≈ $214.84 Million	CN¥-20.22 Million ≈ $-2.96 Million	-0.014x	+28.32%
2013-12-31	CN¥1.47 Billion ≈ $214.44 Million	CN¥-28.16 Million ≈ $-4.12 Million	-0.019x	+88.62%
2012-12-31	CN¥1.63 Billion ≈ $239.18 Million	CN¥-276.02 Million ≈ $-40.39 Million	-0.169x	-561.92%
2011-12-31	CN¥1.80 Billion ≈ $263.72 Million	CN¥65.88 Million ≈ $9.64 Million	0.037x	-43.78%
2010-12-31	CN¥1.61 Billion ≈ $235.47 Million	CN¥104.63 Million ≈ $15.31 Million	0.065x	-79.05%
2009-12-31	CN¥1.02 Billion ≈ $149.30 Million	CN¥316.73 Million ≈ $46.35 Million	0.310x	+61.84%
2008-12-31	CN¥776.46 Million ≈ $113.62 Million	CN¥148.93 Million ≈ $21.79 Million	0.192x	+72.98%
2007-12-31	CN¥742.02 Million ≈ $108.58 Million	CN¥82.28 Million ≈ $12.04 Million	0.111x	+181.49%
2006-12-31	CN¥892.18 Million ≈ $130.55 Million	CN¥35.14 Million ≈ $5.14 Million	0.039x	-26.41%
2005-12-31	CN¥874.86 Million ≈ $128.02 Million	CN¥46.83 Million ≈ $6.85 Million	0.054x	+64.59%
2004-12-31	CN¥893.38 Million ≈ $130.73 Million	CN¥29.05 Million ≈ $4.25 Million	0.033x	-80.35%
2003-12-31	CN¥904.58 Million ≈ $132.37 Million	CN¥149.70 Million ≈ $21.91 Million	0.165x	-24.57%
2002-12-31	CN¥834.94 Million ≈ $122.18 Million	CN¥183.18 Million ≈ $26.81 Million	0.219x	+172.54%
2001-12-31	CN¥755.58 Million ≈ $110.57 Million	CN¥60.82 Million ≈ $8.90 Million	0.081x	-35.25%
2000-12-31	CN¥751.40 Million ≈ $109.95 Million	CN¥93.41 Million ≈ $13.67 Million	0.124x	+65.11%
1999-12-31	CN¥703.50 Million ≈ $102.94 Million	CN¥52.97 Million ≈ $7.75 Million	0.075x	-52.56%
1998-12-31	CN¥448.25 Million ≈ $65.59 Million	CN¥71.14 Million ≈ $10.41 Million	0.159x	--

About Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology

Market Cap

$1.04 Billion

CN¥7.11 Billion CNY

Market Cap Rank

#8424 Global

#1943 in China

Share Price

CN¥4.28

Change (1 day)

+0.23%

52-Week Range

CN¥4.00 - CN¥8.13

All Time High

CN¥9.46